Abstract:Sumoylation is a posttranslational modification implicated in a variety of cellular activities, and its role in a number of human pathogeneses such as cleft lip/palate has been well documented. However, the importance of the SUMO conjugation pathway in cardiac development and functional disorders is newly emerging. We previously reported that knockout of SUMO-1 in mice led to congenital heart diseases (CHDs). To further investigate the effects of imbalanced SUMO conjugation on heart development and function and its underlying mechanisms, we generated transgenic (Tg) mice with cardiac-specific expression of SENP2, a SUMO-specific protease that deconjugates sumoylated proteins, to evaluate the impact of desumoylation on heart development and function. Overexpression of SENP2 resulted in premature death of mice with CHDs—atrial septal defects (ASDs) and/or ventricular septal defects (VSDs). Immunobiochemistry revealed diminished cardiomyocyte proliferation in SENP2-Tg mouse hearts compared with that in wild type (WT) hearts. Surviving SENP2-Tg mice showed growth retardation, and developed cardiomyopathy with impaired cardiac function with aging. Cardiac-specific overexpression of the SUMO-1 transgene reduced the incidence of cardiac structural phenotypes in the sumoylation defective mice. Moreover, cardiac overexpression of SENP2 in the mice with Nkx2.5 haploinsufficiency promoted embryonic lethality and severity of CHDs, indicating the functional interaction between SENP2 and Nkx2.5 in vivo. Our findings indicate the indispensability of a balanced SUMO pathway for proper cardiac development and function. This article is part of a Special Issue entitled ‘Post-translational Modification SI’.

SENP2 Regulates MEF2A De-Sumoylation in an Activity Dependent Manner.

The E3 Ligase APC/C-Cdh1 Regulates MEF2A-dependent Transcription by Targeting SUMO-specific Protease 2 for Ubiquitination and Degradation.

Sumoylation Activates The Transcriptional Activity Of Pax-6, An Important Transcription Factor For Eye And Brain Development

An Essential Role of Small Ubiquitin-like Modifier (Sumo)-Specific Protease 2 in Myostatin Expression and Myogenesis*

Senp1-Mediated Gata1 Desumoylation is Critical for Definitive Erythropoiesis

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

SENP2 Promotes VSMC Phenotypic Switching Via Myocardin De-SUMOylation

SENP1 Enhances Androgen Receptor-Dependent Transcription Through Desumoylation of Histone Deacetylase 1

SENP2 Suppresses Necdin Expression to Promote Brown Adipocyte Differentiation.

SENP2 Regulates Hepatocellular Carcinoma Cell Growth by Modulating the Stability of Β-Catenin

Differential Regulation of C-Jun-dependent Transcription by SUMO-specific Proteases.

SENP3 Regulates the Global Protein Turnover and the Sp1 Level Via Antagonizing SUMO2/ 3-Targeted Ubiquitination and Degradation

SUMO protease SENP1 deSUMOylates and stabilizes c-Myc

SENP2 Negatively Regulates Cellular Antiviral Response by Desumoylating IRF3 and Conditioning It for Ubiquitination and Degradation

Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction

Exploring the Desumoylation Process of SENP1: a Study Combined MD Simulations with QM/MM Calculations on SENP1-SUMO1-RanGAP1.

Data from Mitotic Phosphorylation of SENP3 Regulates DeSUMOylation of Chromosome-Associated Proteins and Chromosome Stability

Mitotic Phosphorylation Of Senp3 Regulates Desumoylation Of Chromosome-Associated Proteins And Chromosome Stability

SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes

Research progression on biologic function and effect of SUMO-specific proteinase

Figure S2 from Mitotic Phosphorylation of SENP3 Regulates DeSUMOylation of Chromosome-Associated Proteins and Chromosome Stability